Burcon Nutrascience ( (TSE:BU) ) has shared an update.
Burcon NutraScience Corporation has successfully completed a rights offering, raising approximately $9.43 million through the issuance of over 110 million common shares. The proceeds are intended to support the commercialization and production scaling of Burcon’s protein products, alongside funding a manufacturing agreement with RE ProMan, LLC. The rights offering was well-supported by strategic investors and insiders, solidifying Burcon’s capital position to pursue growth opportunities.
More about Burcon Nutrascience
Burcon NutraScience Corporation is a global technology leader in the development of plant-based proteins for foods and beverages. The company focuses on commercializing innovative protein products and is involved in scaling production to meet market demands.
YTD Price Performance: 27.78%
Average Trading Volume: 55,780
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $20.09M
See more insights into BU stock on TipRanks’ Stock Analysis page.